Physician profile
Walter Smithwick
NPI 1144292202
$1,327.66
in general payments reported to CMS, 2019-2025
14 companies · $471 in 2025
The $471 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $115 · 2021: $12.15 · 2022: $179 · 2023: $125 · 2024: $250 · 2025: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $828 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $828.06 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $336.25 | 2020-2023 | Tepezza |
| Amgen INC. | $247.52 | 2024-2025 | Tepezza |
| Mallinckrodt Hospital Products INC. | $190.03 | 2023-2025 | Acthar |
| Johnson & Johnson Surgical Vision, INC. | $164.07 | 2019 | |
| Argenx US, INC. | $110.93 | 2025 | |
| Halozyme INC | $76.76 | 2024-2025 | Hylenex Recombinant |
| Tarsus Pharmaceuticals, INC. | $65.69 | 2024-2025 | Xdemvy |
| Rayner Intraocular Lenses Limited | $30.28 | 2025 | Omidria |
| Oyster Point Pharma, INC. | $29.70 | 2022 | |
| Merz North America, INC. | $18.42 | 2020 | |
| Bausch & Lomb Americas INC. | $17.84 | 2024 | Miebo |
| Abbvie INC. | $16.36 | 2025 | |
| Allergan, INC. | $12.54 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Smithwick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.